Please Wait...

Bioclinica's Research Network Goes Global with Compass Acquisition

Bioclinica's extensive Research Network of full-service clinical study sites – already located in Asia, Europe, and Latin America – achieved a global status with the recent acquisition of Compass Research. As reviewed in the CenterWatch Weekly publication, the acquisition will expand Bioclinica's Research Network into the U.S., providing a true global site network for pharmaceutical companies engaged in clinical research.

Sean Stanton, co-founder and CEO of Compass Research, is enthusiastic about joining Bioclinica. "We have been growing organically since the inception of the business 10 years ago. Joining Bioclinica's Site Network allows us to grow more rapidly. They have the resources, the leadership, and the adjacent service units which will allow us to grow faster and better than we could have alone," said Stanton.

Elizabeth Thiele, president of Global Clinical Research for Bioclinica, affirmed, "By joining Bioclinica, Compass Research will become part of a global organization focused on bringing clarity to clinical trials. This expansion into the U.S. allows us to offer our full line of services to an even broader population of customers."

Read the full article on Bioclinica's global expansion here.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Come talk to Bioclinica at #ASCO19! See why we're the world leader in #oncology imaging, helping to assess efficacy… https://t.co/MyomMS0Rvt
Bioclinica (Yesterday)
Great insights for sponsors conducting #NAFLD #NASH #clinicaltrials. https://t.co/TG1WwRhVE8
Bioclinica (2 days ago)
In Beijing for DIA China next week? If so, drop by Bioclinica's exhibit or catch our talk in the Randomization & Cl… https://t.co/LCNpNHabo2
Bioclinica (4 days ago)
Greetings from Milan! Bioclinica looks forward to connecting with our #pharma and #CRO friends at #octEurope! Raggy… https://t.co/KqG99HqDWA
Bioclinica (5 days ago)
Could EDC software be a game changer in your clinical trial? Here's what to look for in evaluating different syste… https://t.co/MyxooYMwqk
Bioclinica (5 days ago)
This week at OCT Europe, #pharma #CRO companies can get a look at Bioclinica's award-winning clinical adjudication… https://t.co/jzEexOMDZA
Bioclinica (5 days ago)

Latest Blogs:

Medical Imaging of Non-Alcoholic Fatty Liver Diseases in Clinical Trials
EDC Provider Selection
Site Payments Solutions
Nonalcoholic steatohepatitis (NASH) development programs
Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box